Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins: all 582 studies

Page 2 of 6. Open to participants first (72), then studies with results posted, then the rest; newest registration first within each.

• Pathologic and Immunologic Response After Ablative Radiation in Lung CancerCompletedNCT03603002Not applicableResults posted
• Combined Technology Enhanced Home Exercise Program and Other Non-pharmacological Intervention for Cancer SurvivorsCompletedNCT03576274Not applicableResults posted
• COMbination of Bipolar Androgen Therapy and NivolumabCompletedNCT03554317Phase 2Results posted
• A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic CancerCompletedNCT03535727Phase 1/2Results posted
• Muscadine Plus (MPX) In Men With Prostate CancerTerminatedNCT03535675Phase 3Results posted
• Assessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen SuppressionCompletedNCT03507608Early Phase 1Results posted
• Nivolumab With Ipilimumab in Subjects With Neuroendocrine TumorsTerminatedNCT03420521Phase 2Results posted
• Trial of Rucaparib in Patients With Metastatic Hormone-Sensitive Prostate Cancer Harboring Germline DNA Repair Gene MutationsCompletedNCT03413995Phase 2Results posted
• Radiosurgical Hypophysectomy for Bone Metasteses PainTerminatedNCT03377517Not applicableResults posted
• Allogeneic Myeloma GM-CSF Vaccine With Lenalidomide in Multiple Myeloma Patients in Complete or Near Complete RemissionTerminatedNCT03376477Phase 2Results posted
• Radiopaque Hydrogel in Patients Undergoing Radiotherapy for Pancreatic CancerCompletedNCT03307564Not applicableResults posted
• Involving Family to Improve Communication in Breast Cancer CareCompletedNCT03283553Not applicableResults posted
• A Clinical Trial of Entinostat in Combination With Nivolumab for Patients With Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic AdenocarcinomaCompletedNCT03250273Phase 2Results posted
• Clinical Trial of Combined Fostamatinib and Paclitaxel in Ovarian CancerCompletedNCT03246074Phase 1Results posted
• Neoadjuvant Immunoradiation for Resectable Non-Small Cell Lung CancerTerminatedNCT03237377Phase 2Results posted
• MEDI-551 as Maintenance Therapy After Allogeneic Stem Cell Transplant in Multiple MyelomaTerminatedNCT03218163Phase 2Results posted
• HIF-2 Alpha Inhibitor PT2385 in Treating Patients With Recurrent GlioblastomaCompletedNCT03216499Phase 2Results posted
• Study of CRS-207, Nivolumab, and Ipilimumab With or Without GVAX Pancreas Vaccine (With Cy) in Patients With Pancreatic CancerCompletedNCT03190265Phase 2Results posted
• GVAX Pancreas Vaccine (With CY) in Combination With Nivolumab and SBRT for Patients With Borderline Resectable Pancreatic CancerCompletedNCT03161379Phase 2Results posted
• Pilot Study With CY, Pembrolizumab, GVAX, and IMC-CS4 (LY3022855) in Patients With Borderline Resectable Adenocarcinoma of the PancreasCompletedNCT03153410Early Phase 1Results posted
• Idelalisib Post Allogeneic Hematopoietic Stem Cell Transplant (HSCT) in B Cell Derived MalignanciesTerminatedNCT03151057Phase 1Results posted
• Pembrolizumab in Patients With Leptomeningeal DiseaseTerminatedNCT03091478Phase 2Results posted
• Olaparib in Men With High-Risk Biochemically-Recurrent Prostate Cancer Following Radical Prostatectomy, With Integrated Biomarker AnalysisActive, not recruitingNCT03047135Phase 2Results posted
• A Study of Definitive Therapy to Treat Prostate Cancer After ProstatectomyCompletedNCT03043807Phase 2Results posted
• Study of Stereotactic Radiotherapy for Breast CancerTerminatedNCT03043794Phase 2Results posted
• Simplifying Survivorship Care PlanningCompletedNCT03035773Not applicableResults posted
• Epacadostat, Pembrolizumab, and CRS-207, With or Without CY/GVAX Pancreas in Patients With Metastatic Pancreas CancerCompletedNCT03006302Phase 2Results posted
• Sex-Mismatched Allogeneic Bone Marrow Transplantation for Men With Metastatic Castration-Resistant Prostate CancerTerminatedNCT02995330Phase 1Results posted
• Study of GVAX (With CY) and Pembrolizumab in MMR-p Advanced Colorectal CancerCompletedNCT02981524Phase 2Results posted
• Neoadjuvant Enoblituzumab (MGA271) in Men With Localized Intermediate and High-Risk Prostate CancerActive, not recruitingNCT02923180Phase 2Results posted
• Phase 2 Study of Nivolumab in Solid Tumors Induced by Prior Radiation ExposureTerminatedNCT02864316Phase 2Results posted
• Study of Azacitidine in Combination With Pembrolizumab in R/R AML Patients and in Newly Diagnosed Older PatientsCompletedNCT02845297Phase 2Results posted
• NMA Haplo or MUD BMT for Newly Diagnosed Severe Aplastic AnemiaCompletedNCT02833805Phase 2Results posted
• Ultrasound Monitoring of Abdominal Soft TissueTerminatedNCT02722616Not applicableResults posted
• A Study of Definitive Therapy to Treat Prostate CancerCompletedNCT02716974Phase 2Results posted
• Stereotactic Body Radiation for Prostate OligometastasesCompletedNCT02680587Phase 2Results posted
• Study With CY, Pembrolizumab, GVAX Pancreas Vaccine, and SBRT in Patients With Locally Advanced Pancreatic CancerCompletedNCT02648282Phase 2Results posted
• Biomarker-Driven Therapy With Nivolumab and Ipilimumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Expressing AR-V7CompletedNCT02601014Phase 2Results posted
• Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft MalignanciesCompletedNCT02556931Phase 2Results posted
• Pilot Study of 18F-DCFPyL PET/CT in the Evaluation of Men With an Elevated PSA Following Radical ProstatectomyCompletedNCT02523924Not applicableResults posted
• Docetaxel With or Without Ascorbic Acid in Treating Patients With Metastatic Prostate CancerTerminatedNCT02516670Phase 2Results posted
• Dexamethasone Prior to Re-treatment With Enzalutamide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Enzalutamide and DocetaxelTerminatedNCT02491411Not applicableResults posted
• Utilizing Advance Care Planning Videos to Empower Perioperative Cancer Patients and FamiliesCompletedNCT02489799Not applicableResults posted
• Pembrolizumab and Cryosurgery in Treating Patients With Newly Diagnosed, Oligo-metastatic Prostate CancerCompletedNCT02489357Not applicableResults posted
• Study of Sipuleucel-T W/ or W/O Radium-223 in Men With Asymptomatic or Minimally Symptomatic Bone-MCRPCCompletedNCT02463799Phase 2Results posted
• Survivorship Promotion In Reducing IGF-1 TrialCompletedNCT02431676Phase 2Results posted
• Safety and Feasibility of TA-CIN Vaccine in HPV16 Associated Cervical CancerCompletedNCT02405221Phase 1Results posted
• Brain Interstitium Temozolomide Concentration Pre and Post Regadenoson AdministrationCompletedNCT02389738Early Phase 1Results posted
• Intravaginal Artesunate for the Treatment of HPV+ High Grade Cervical Intraepithelial Neoplasia (CIN2/3)CompletedNCT02354534Phase 1Results posted
• Study of Gemcitabine/Taxotere/Xeloda (GTX) in Combination With Cisplatin and Irinotecan in Subjects With Metastatic Pancreatic CancerCompletedNCT02324543Phase 1/2Results posted
• Testosterone Revival Abolishes Negative Symptoms, Fosters Objective Response and Modulates Enzalutamide ResistanceCompletedNCT02286921Phase 2Results posted
• Neoadjuvant Nivolumab, or Nivolumab in Combination With Ipilimumab, in Resectable NSCLCActive, not recruitingNCT02259621Phase 2Results posted
• GVAX Pancreas Vaccine (With CY) and CRS-207 With or Without NivolumabCompletedNCT02243371Phase 2Results posted
• Intraoperative Dosimetry for Prostate Brachytherapy Using Fluoroscopy and UltrasoundCompletedNCT02225925Not applicableResults posted
• Transplantation of Partially Mismatched Related or Matched Unrelated Bone Marrow for Patients With Refractory Severe Aplastic AnemiaCompletedNCT02224872Phase 2Results posted
• Study Assessing the Feasibility of a Surgery and Chemotherapy-Only in Children With Wnt Positive MedulloblastomaTerminatedNCT02212574Early Phase 1Results posted
• Randomized Salvage Radiation Therapy Plus Enzalutamide Post ProstatectomyCompletedNCT02203695Phase 2Results posted
• Myeloablative Haploidentical BMT With Post-transplant Cyclophosphamide for Pediatric Patients With Hematologic MalignanciesCompletedNCT02120157Phase 2Results posted
• A Study of Vismodegib in Men With Metastatic CRPC With Accessible Metastatic Lesions for Tumor BiopsyCompletedNCT02115828Early Phase 1Results posted
• A Pre-surgical Study of LDE225 in Men With High-risk Localized Prostate CancerCompletedNCT02111187Phase 1Results posted
• Scrambler Therapy in the Treatment of Chronic Chemotherapy-Induced Peripheral NeuropathyCompletedNCT02111174Not applicableResults posted
• Detection and Prevention of Anthracycline-Related Cardiac Toxicity With Concurrent SimvastatinTerminatedNCT02096588Phase 2Results posted
• RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistance (The RESTORE Study)CompletedNCT02090114Phase 2Results posted
• Nonmyeloablative Conditioning and Transplantation for Patients With Refractory Systemic Lupus Erythematosus (SLE)TerminatedNCT02080195Phase 1/2Results posted
• Chemoradiation or Brachytherapy for Rectal CancerCompletedNCT02017704Phase 2Results posted
• Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast CancerActive, not recruitingNCT01937117Phase 2Results posted
• Phase II Anti-PD1 Epigenetic Therapy Study in NSCLC.CompletedNCT01928576Phase 2Results posted
• FOLFIRINOX Followed by Ipilimumab With Pancreatic Tumor Vaccine in Treatment of Metastatic Pancreatic CancerCompletedNCT01896869Phase 2Results posted
• Phase I/II Study of SGI-110 With Irinotecan Versus Regorafenib or TAS-102 in Metastatic Colorectal CancerCompletedNCT01896856Phase 1/2Results posted
• Combination of External Beam Radiotherapy With 153Sm-EDTMP to Treat High Risk OsteosarcomaTerminatedNCT01886105Phase 2Results posted
• Study of MK-3475 in Patients With Microsatellite Unstable (MSI) Tumors (Cohorts A, B and C)CompletedNCT01876511Phase 2Results posted
• Tadalafil and Lenalidomide Maintenance With or Without Activated Marrow Infiltrating Lymphocytes (MILs) in High Risk MyelomaCompletedNCT01858558Phase 2Results posted
• Trial to Improve Outcomes in Patients With Resected Pancreatic Cancer (Azacitidine)CompletedNCT01845805Phase 2Results posted
• Evaluation of 18F-DCFBC PSMA-based PET Imaging for Detection of Metastatic Prostate CancerCompletedNCT01815515Phase 1/2Results posted
• Hippocampal Prophylactic Cranial Irradiation for Small Cell Lung CancerCompletedNCT01797159Not applicableResults posted
• Palliative Stereotactic Radiation for Pancreatic or Periampullary AdenocarcinomaCompletedNCT01781728Phase 2Results posted
• Stereotactic Radiation Therapy for Pediatric SarcomasCompletedNCT01763970Not applicableResults posted
• DIG-HIF-1 Pharmacodynamic Trial in Newly Diagnosed Operable Breast CancerCompletedNCT01763931Phase 2Results posted
• Radiotherapy for Solid Tumor Spine MetastasesCompletedNCT01752036Phase 2Results posted
• A Randomized Phase II Study of SUBATM-itraconazole in Patients With Untreated Squamous NSCLC.TerminatedNCT01752023Phase 2Results posted
• Bipolar Androgen-based Therapy for Prostate Cancer (BAT)CompletedNCT01750398Phase 2Results posted
• A Phase I/II Study Afatinib/Carboplatin/Paclitaxel Induction Chemotherapy In HPV-Negative HNSCC.TerminatedNCT01732640Phase 1/2Results posted
• Stereotactic Body Radiation With Nelfinavir for OligometastasesCompletedNCT01728779Phase 2Results posted
• Phase II Study Using CHFR Methylation Status in Patients With Metastatic Esophageal, Gastroesophageal, Gastric Cancer.CompletedNCT01715233Phase 2Results posted
• A Phase 1 Trial of TST of PD 0332991 Followed by Cytarabine and Mitoxantrone for Adults With Relapsed and Refractory Acute Leukemias and High-Risk MyelodysplasiaTerminatedNCT01701375Phase 1Results posted
• Phase II Study of Azacitidine and Sargramostim as Maintenance Treatment for Poor-Risk AML or MDSCompletedNCT01700673Phase 2Results posted
• A Phase II Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive TractCompletedNCT01697800Phase 2Results posted
• A Neoadjuvant Study of Androgen Ablation Combined With Cyclophosphamide and GVAX Vaccine for Localized Prostate CancerCompletedNCT01696877Phase 1/2Results posted
• Maintenance Rituximab With mTor Inhibition After High-dose Consolidative Therapy in LymphomaCompletedNCT01665768Phase 2Results posted
• Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Metastatic Colorectal AdenocarcinomaTerminatedNCT01639131Phase 2Results posted
• Pancreatic Tumor Cell Vaccine (GVAX), Cyclophosphamide, SBRT, and FOLFIRINOX in Patients With Resected Adenocarcinoma of the PancreasCompletedNCT01595321Phase 2Results posted
• A Feasibility Study of a Modular Video Augmentation System for Image-Guided Skull Base SurgeryTerminatedNCT01591954Not applicableResults posted
• Consolidation Therapy for Acute Myeloid Leukemia Guided by Leukemia Stem Cell BehaviorTerminatedNCT01588951Phase 2/3Results posted
• Study of Metformin Plus Paclitaxel/Carboplatin/Bevacizumab in Patients With Adenocarcinoma.TerminatedNCT01578551Phase 2Results posted
• Radiation and Androgen Ablation for Prostate CancerCompletedNCT01517451Phase 1/2Results posted
• Evaluation of Prostate-specific Membrane Antigen (PSMA)-Based PET Imaging of Primary Prostate CancerCompletedNCT01496157Phase 1/2Results posted
• Neural Progenitor Cell Sparing Radiation Therapy Plus TemozolomideCompletedNCT01478854Not applicableResults posted
• Pre-Prostatectomy Lovastatin on Prostate CancerTerminatedNCT01478828Not applicableResults posted
• Low Dose Radiation Therapy for Glioblastoma MultiformeCompletedNCT01466686Phase 2Results posted
• Gemcitabine/Taxotere/Xeloda (GTX) With Cisplatin in Subjects With Metastatic Pancreatic CancerCompletedNCT01459614Phase 2Results posted

← Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins overview and focus areas